India gets new Covid medicine, developed by DRDO: How it works, how to use
Published on May 08, 2021 06:42 pm IST
- As India struggles against a devastating wave of Covid-19 infections, authorities cleared a medicine developed by Defence Research & Development Organisation's INMAS (Institute of Nuclear Medicine & Allied Sciences), and pharma major Dr Reddy's Laboratories. The anti-Covid application of 2-deoxy-D-glucose (2-DG) has been found to help in faster recovery of hospitalised patients, and reduce supplemental oxygen dependence, as per clinical trials. Watch the full video for more.
RELATED VIDEOS
India Silently Rushes Warships Near Houthi Territory After U.S. Forms Red Sea Force | Watch
Published on Dec 19, 2023 08:38 pm IST
India calls-out W.H.O Covid death data at Geneva; conveys ‘disappointment’
Published on May 24, 2022 07:41 am IST
Paid Covid booster doses for Indian adults: Prices, Availability | Key details
Published on Jul 25, 2023 03:21 pm IST
How Shanghai is grappling with biggest-ever Covid outbreak
Published on Apr 06, 2022 11:08 pm IST
XE a ‘recombinant’: What we know of the new Covid variant reported from Mumbai
Published on Apr 06, 2022 09:56 pm IST
PM Modi clarifies on migrant crisis; says, ‘States imposed lockdown first’
Published on Feb 10, 2022 09:08 am IST
Hi, {{name}}
Sign out
{{planName}}
{{^userSubscribed}}
{{/userSubscribed}}